Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Histone Methylation Silences Genes

By Biotechdaily staff writers
Posted on 12 Nov 2002
Researchers have established a link between histone methylation and Polycomb group proteins (PcG)-mediated gene silencing in the developing embryo. More...
This finding was reported in the November 1, 2002, issue of Science.

Gene silencing is crucial for normal embryonic development. When the developing embryo no longer requires the products of a particular gene, that gene must be permanently turned off (silenced). The Hox genes, which are expressed in early embryonic development and then silenced by the action of proteins produced by the Polycomb group of genes, have been of particular interest. Embryos from animals with mutated or missing Polycomb genes fail to silence the Hox genes, and the embryos do not develop normally.

In the current study, investigators from the University of North Carolina School of Medicine (Chapel Hill, USA) described the purification and characterization of a Polycomb group protein complex. "Basically, we found that the Polycomb proteins function through methylating a particular lysine residue, lysine 27, on histone 3,” explained senior author Dr. Yi Zhang, UNC assistant professor of biochemistry and biophysics.

When enzyme activity causing methylation of this site is blocked, Hox gene silencing does not occur. The permanent silencing of the Hox genes was explained by the observation that histone methylation cannot be reversed. In Dr. Zhang's words, "Thus far, no ‘histone demethylase' has been discovered.”



Related Links:
Univ. of NC School of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
POC Immunoassay Analyzer
Procise DX
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.